+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin: Correlation with cytotoxicity



Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin: Correlation with cytotoxicity



Biochemical Pharmacology 45(7): 1503-1515



Dolastatin 10 is a potent antimitotic peptide isolated from the marine mollusk Dolabella auricularia. Four of its five residues are modified amino acids (in sequence, dolavaline, valine, dolaisoleuine, dolaproine, dolaphenine). Besides inhibiting tubulin polymerization, dolastatin 10 non-competitively inhibits vinca alkaloid binding to tubulin, inhibits nucleotide exchange and formation of the beta s cross-link, and stabilizes the colchicine binding activity of tubulin. To examine the mechanism of action of dolastatin 10 we prepared six chiral isomers, one tri- and one tetrapeptide segment, and one pentapeptide analog of dolastatin 10, all of which differ little from dolastatin 10 as inhibitors of tubulin polymerization. However, only two of the chiral isomers were similar to dolastatin 10 in their cytotoxicity for L1210 murine leukemia cells and in their effects on vinblastine binding, nucleotide exchange, beta s cross-link formation, and colchicine binding. These were isomer 2, with reversal of configuration at position C(19a) in the dolaisoleuine moiety, and isomer 19, with reversal of configuration at position C(6) in the dolaphenine moiety. The pentapeptides with reduced cytotoxicity and reduced effects on tubulin interactions with other ligands were all modified in the dolaproine moiety at positions C(9) and/or C(10). The tripeptide and tetrapeptide segments which inhibited polymerization but not ligand interactions were the amino terminal tripeptide (lacking dolaproine and dolaphenine) and the carboxyl terminal tetrapeptide (lacking dolavaline). We speculate that strong inhibition of other ligand interactions with tubulin requires stable peptide binding to tubulin (i.e. slow dissociation), but that inhibition of polymerization requires only rapid binding to tubulin.

(PDF emailed within 0-6 h: $19.90)

Accession: 008470656

Download citation: RISBibTeXText

PMID: 8471072

DOI: 10.1016/0006-2952(93)90051-w


Related references

Cytotoxicity of dolastatin 10 dolastatin 15 and dolastatin k333 human tumor xenografts in vitro. Proceedings of the American Association for Cancer Research Annual Meeting 32: 402, 1991

Structure-activity studies with chiral isomers and with segments of the antimitotic marine peptide dolastatin 10. Biochemical Pharmacology 40(8): 1859-1864, 1990

Diethylstilbestrol metabolites and analogs: differential ligand effects on estrogen receptor interactions with nuclear matrix sites. Endocrinology 128(4): 1785-1791, 1991

Interactions of radiolabeled dolastatin 10 with tubulin. Proceedings of the American Association for Cancer Research Annual Meeting 35(0): 399, 1994

Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1. Biochemistry 38(43): 14302-14310, 1999

Intracellular activation and deactivation of tasidotin, an analog of dolastatin 15: correlation with cytotoxicity. Molecular Pharmacology 75(1): 218-226, 2008

Differential effects of taxol analogs modified at positions C and C on tubulin polymerization and polymer stabilization. Proceedings of the American Association for Cancer Research Annual Meeting 34(0): 350, 1993

Halichondrin B and homohalichondrin B, marine natural products binding in the vinca domain of tubulin. Discovery of tubulin-based mechanism of action by analysis of differential cytotoxicity data. Journal of Biological Chemistry 266(24): 15882-9, 1991

Differential effects of magnesium on tubulin-nucleotide interactions. Biochimica et Biophysica Acta 832(1): 22-32, 1985

The differential effects of quinidine and optically active isomers on IKr and GI contractility. Journal of Investigative Medicine 50(2): 176A, March, 2002

Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricularia. Interaction with tubulin and effects of cellular microtubules. Biochemical Pharmacology 43(12): 2637-2645, 1992

Design of combretastatin A-4 analogs as tubulin targeted vascular disrupting agent with special emphasis on their cis-restricted isomers. Current Pharmaceutical Design 19(10): 1923-1955, 2013

Differential effects of ethyl 5-amino-2-methyl-1,2-dihydro-3-phenylpyrido[3,4-b]pyrazin-7-yl carbamate analogs modified at position C2 on tubulin polymerization, binding, and conformational changes. Biochemistry 34(51): 16821-9, 1995